CORC

在结果中检索

CORC

浏览/检索结果: 共21条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Nitidine chloride exerts anti-inflammatory action by targeting Topoisomerase I and enhancing IL-10 production 期刊论文
2019, 卷号: 148, 页码: 104368
作者:  Yang Niao;  Yue Rongcai;  Ma Jinzhu;  Li Wencai;  Zhao Zeng
收藏  |  浏览/下载：39/0  |  提交时间：2020/01/03
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase I 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 28
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载：43/0  |  提交时间：2020/01/03
A validated UPLC-MS/MS method to determine free and total irinotecan and its two metabolites in human plasma after intravenous administration of irinotecan hydrochloride liposome injection 期刊论文
2019, 卷号: 170, 页码: 112-123
作者:  Zhuang, Quankun;  Liu, Xuemei;  Sun, Zhuo;  Wang, Hongyun;  Jiang, Ji
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 16
作者:  Huang, Jing;  Xu, Binghe;  Liu, Ying;  Huang, Junxing;  Lu, Ping
收藏  |  浏览/下载：31/0  |  提交时间：2020/01/03
Comparative intestinal bacteria-associated pharmacokinetics of 16 components of Shengjiang Xiexin decoction between normal rats and rats with irinotecan hydrochloride (CPT-11)-induced gastrointestinal toxicity in vitro using salting-out sample pr 期刊论文
2017, 卷号: 7, 期号: 69, 页码: 43621-43635
作者:  Guan, Huanyu;  Wang, Xiaoming;  Wang, Shiping;  He, Yang;  Yue, Jiajing
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity 期刊论文
2017, 卷号: 8, 页码: 769
作者:  Guan, Huan-yu;  Li, Peng-fei;  Wang, Xiao-ming;  Yue, Jia-jing;  He, Yang
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
A phase III trial (ZJBI0009): CMABOO9 plus irinotecan versus irinotecan alone as second-line treatment after fluoropyrimidine and oxaliplatin failure in wild-type K-ras metastatic colorectal cancer patients. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Cheng, Ying;  Liu, Wei
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04
A phase III trial (ZJBI0009): CMABOO9 plus irinotecan versus irinotecan alone as second-line treatment after fluoropyrimidine and oxaliplatin failure in wild-type K-ras metastatic colorectal cancer patients. 期刊论文
2017, 卷号: 35
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Cheng, Ying;  Liu, Wei
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04
Molecular Genetics External Quality Assessment Pilot Scheme for Irinotecan-Related UGT1A1 Genotyping in China 期刊论文
2016, 卷号: 11, 期号: 1
作者:  Yi, Lang;  Lin, Guigao;  Zhang, Kuo;  Wang, Lunan;  Zhang, Rui
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04
Irinotecan plus fluorouracil-based regimen as second or third-line chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma 期刊论文
2016, 卷号: 7, 期号: 2, 页码: 246-250
作者:  Wang, Xi;  Wang, Xinwei;  Huang, Jing
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace